No evidence that AY.4.2 COVID variant causes more severe course of disease, expert says

According to Vasily Akimkin, existing publications do not demonstrate convincing proof of differences in the risks of hospitalization or mortality between the detected new gene variant and the baseline of the Delta gene variant

Related Keywords

Moscow ,Moskva ,Russia ,United Kingdom ,Tatarstan ,British ,Kamil Khafizov ,Central Scientific Research Institute Of Epidemiology ,Central Research Institute ,Federal Service ,Consumer Rights Protection ,Human Wellbeing Vasily Akimkin ,Central Scientific Research Institute ,Moscow Region ,Genetics Institute ,University College London Francois Balloux ,